Cynthia Shannon Weickert
#160,145
Most Influential Person Now
Researcher
Cynthia Shannon Weickert's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Cynthia Shannon Weickert Influential?
(Suggest an Edit or Addition)Cynthia Shannon Weickert's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
- Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia (2003) (516)
- Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia (2013) (483)
- Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group (2017) (423)
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis (2011) (392)
- Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. (2004) (365)
- Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium (2018) (343)
- Transcriptional neoteny in the human brain (2009) (330)
- Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. (2006) (323)
- Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. (2010) (317)
- Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. (2007) (309)
- Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. (2011) (300)
- Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia (2006) (249)
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia (2012) (220)
- Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease (2008) (208)
- BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. (2006) (208)
- BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs (2001) (201)
- Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume (2015) (197)
- Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus (2004) (187)
- Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder (2014) (182)
- Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients (2008) (181)
- BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. (2002) (179)
- Rethinking schizophrenia in the context of normal neurodevelopment (2013) (176)
- Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia (2005) (176)
- Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. (2006) (175)
- Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. (2010) (170)
- Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. (2009) (163)
- Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness (2004) (162)
- Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain (2004) (161)
- Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia (2008) (155)
- Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia (2003) (150)
- Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. (2004) (149)
- Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain (2014) (148)
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia (2019) (144)
- Age-related differences in glucocorticoid receptor mRNA levels in the human brain (2007) (143)
- Emotional face processing in schizophrenia. (2009) (143)
- Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression (2016) (143)
- Accelerated Gray and White Matter Deterioration With Age in Schizophrenia. (2017) (142)
- Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients (2008) (141)
- Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation (2018) (139)
- Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone (2000) (136)
- International randomized-controlled trial of transcranial Direct Current Stimulation in depression (2018) (132)
- Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation (2003) (130)
- Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders (2014) (127)
- Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development (2003) (123)
- Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation (2012) (121)
- Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia (2015) (117)
- Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development (2010) (114)
- Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation (2014) (112)
- Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia (2009) (111)
- Biomarkers in Schizophrenia: A Brief Conceptual Consideration (2013) (110)
- Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder (2017) (103)
- Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs (2003) (103)
- Neuroplasticity in Depressed Individuals Compared with Healthy Controls (2013) (103)
- SELECTION OF REFERENCE GENE EXPRESSION IN A SCHIZOPHRENIA BRAIN COHORT (2010) (102)
- Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation (2016) (102)
- White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs (2016) (101)
- The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
- Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia (2011) (97)
- Transcranial direct current stimulation influences probabilistic association learning in schizophrenia (2011) (94)
- Alteration in Estrogen Receptor α mRNA Levels in Frontal Cortex and Hippocampus of Patients with Major Mental Illness (2005) (93)
- Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra (2012) (93)
- Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia (2010) (91)
- Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. (2020) (89)
- Developmental changes in human dopamine neurotransmission: cortical receptors and terminators (2012) (89)
- Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease (2006) (88)
- Gene Expression of Metabolic Enzymes and a Protease Inhibitor in the Prefrontal Cortex Are Decreased in Schizophrenia (2004) (88)
- Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA (2020) (87)
- Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring (2017) (86)
- Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive Decline. (2016) (85)
- Cell proliferation is reduced in the hippocampus in schizophrenia (2015) (84)
- Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers (2017) (83)
- Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway (2014) (79)
- Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. (1995) (79)
- Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness (2013) (78)
- Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers (2014) (76)
- Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex (2012) (74)
- Higher Gamma-Aminobutyric Acid Neuron Density in the White Matter of Orbital Frontal Cortex in Schizophrenia (2012) (74)
- Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity (2012) (72)
- PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia (2017) (70)
- Identification of Sialyltransferase 8B as a Generalized Susceptibility Gene for Psychotic and Mood Disorders on Chromosome 15q25-26 (2012) (70)
- Striatal TGF-alpha: postnatal developmental expression and evidence for a role in the proliferation of subependymal cells. (1995) (69)
- Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders (2017) (67)
- Changes in alternative brain‐derived neurotrophic factor transcript expression in the developing human prefrontal cortex (2009) (66)
- Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors (2020) (66)
- Neuregulin-1 and schizophrenia in the genome-wide association study era (2016) (65)
- Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus (2001) (65)
- Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants (2012) (65)
- Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia (2001) (65)
- Evidence for Network-Based Cortical Thickness Reductions in Schizophrenia. (2019) (64)
- Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain (2007) (64)
- The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes (2015) (64)
- Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation (2019) (63)
- Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia. (2013) (63)
- Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. (2009) (62)
- Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development (2011) (61)
- Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression. (2014) (60)
- Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. (2001) (60)
- Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex (2005) (59)
- Association of serum VEGF levels with prefrontal cortex volume in schizophrenia (2016) (59)
- C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls (2018) (57)
- Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia. (2014) (55)
- Reduced neural activity of the prefrontal cognitive control circuitry during response inhibition to negative words in people with schizophrenia. (2012) (54)
- Lack of Change in Markers of Presynaptic Terminal Abundance Alongside Subtle Reductions in Markers of Presynaptic Terminal Plasticity in Prefrontal Cortex of Schizophrenia Patients (2011) (51)
- GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice (1995) (50)
- Abnormal Glucocorticoid Receptor mRNA and Protein Isoform Expression in the Prefrontal Cortex in Psychiatric Illness (2011) (49)
- Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA) (2016) (48)
- Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder (2012) (48)
- Spatial and temporal diversity of glycome expression in mammalian brain (2020) (45)
- Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNA (2019) (45)
- Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia (2004) (45)
- Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia (2015) (44)
- Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression. (2014) (44)
- Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans (2011) (43)
- Long Non-Coding RNA Expression during Aging in the Human Subependymal Zone (2015) (43)
- Developmental co-regulation of the β and γ GABAA receptor subunits with distinct α subunits in the human dorsolateral prefrontal cortex (2010) (43)
- Widespread Volumetric Reductions in Schizophrenia and Schizoaffective Patients Displaying Compromised Cognitive Abilities (2018) (42)
- Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain (2017) (42)
- Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation (2015) (42)
- Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia (2020) (41)
- Investigation of peripheral complement factors across stages of psychosis (2019) (41)
- Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related Transcripts (2016) (40)
- Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition (2014) (39)
- Apolipoprotein‐D expression is increased during development and maturation of the human prefrontal cortex (2009) (39)
- Markers of inflammation in the prefrontal cortex of individuals with schizophrenia (2013) (38)
- Basic fibroblast growth factor and fibroblast growth factor receptor-1 in the human hippocampal formation (2005) (38)
- A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain. (2005) (38)
- Developmental Patterns of Doublecortin Expression and White Matter Neuron Density in the Postnatal Primate Prefrontal Cortex and Schizophrenia (2011) (37)
- Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia. (2013) (37)
- Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients (2018) (35)
- Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology (2012) (34)
- Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia* (2009) (34)
- Nestin-Positive Ependymal Cells Are Increased in the Human Spinal Cord after Traumatic Central Nervous System Injury. (2015) (34)
- Discordant changes in cortical TrkC mRNA and protein during the human lifespan (2005) (33)
- High White Matter Neuron Density with Elevated Cortical Cytokine Expression in Schizophrenia (2014) (33)
- ABCA8 stimulates sphingomyelin production in oligodendrocytes. (2013) (32)
- The effect of gonadectomy on prepulse inhibition and fear-potentiated startle in adolescent rhesus macaques (2010) (32)
- In Vivo Imaging of Translocator Protein in Long-term Cannabis Users. (2019) (30)
- Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia (2015) (30)
- Gonadectomy increases neurogenesis in the male adolescent rhesus macaque hippocampus (2014) (29)
- Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals. (2020) (29)
- The effect of adolescent testosterone on hippocampal BDNF and TrkB mRNA expression: relationship with cell proliferation (2015) (28)
- Neuroinflammation in schizophrenia: the role of nuclear factor kappa B (2021) (28)
- Gonadectomy negatively impacts social behavior of adolescent male primates (2009) (28)
- Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice (2017) (27)
- Neonatal lipopolysaccharide treatment has long‐term effects on monoaminergic and cannabinoid receptors in the rat (2013) (27)
- Considering the role of adolescent sex steroids in schizophrenia (2018) (26)
- Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia (2012) (25)
- Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation (2016) (24)
- Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study (2015) (24)
- Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines (2020) (24)
- The Impact of Childhood Adversity on Cognitive Development in Schizophrenia. (2019) (24)
- Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients (2017) (24)
- Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia (2019) (23)
- Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions (2021) (22)
- Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status. (2015) (22)
- Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse (2015) (22)
- Genome-wide association study identifies 30 loci associated with bipolar disorder (2019) (22)
- White matter neuron biology and neuropathology in schizophrenia (2019) (21)
- Increases in [3H]Muscimol and [3H]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to α4 and γ2S mRNA Levels Respectively (2013) (20)
- A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone (2021) (20)
- Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial (2020) (20)
- Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia (2013) (19)
- Neutrophil–lymphocyte ratio – a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders? (2020) (19)
- Full length TrkB potentiates estrogen receptor alpha mediated transcription suggesting convergence of susceptibility pathways in schizophrenia (2011) (19)
- Changes in NMDA Receptor Subunit mRNAs and Cyclophilin mRNA during Development of the Human Hippocampus (2003) (18)
- Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes. (2004) (18)
- Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia (2012) (18)
- Levels of glial cell line‐derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease (2019) (18)
- Important unanswered questions about adult neurogenesis in schizophrenia (2019) (18)
- Cognitive reserve attenuates age-related cognitive decline in the context of putatively accelerated brain ageing in schizophrenia-spectrum disorders (2019) (18)
- Regional, cellular and species difference of two key neuroinflammatory genes implicated in schizophrenia (2020) (18)
- Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia (2016) (18)
- Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia (2017) (18)
- Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats (2000) (18)
- Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia (2018) (18)
- Schizophrenia-relevant behaviours of female mice overexpressing neuregulin 1 type III (2018) (17)
- Epidermal growth factor receptor expression is related to post-mitotic events in cerebellar development: regulation by thyroid hormone. (2003) (17)
- Specific developmental reductions in subventricular zone ErbB1 and ErbB4 mRNA in the human brain (2008) (17)
- Neuropathology of Suicide (1997) (16)
- Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex (2018) (16)
- Brain antibodies in the cortex and blood of people with schizophrenia and controls (2017) (16)
- Expression of DISC 1 binding partners is reduced in schizophrenia and associated with DISC 1 SNPs (2006) (15)
- Endogenous testosterone levels are associated with neural activity in men with schizophrenia during facial emotion processing (2015) (15)
- Temporal proteomic profiling of postnatal human cortical development (2018) (14)
- Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect? (2017) (14)
- Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype (2016) (14)
- Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia (2021) (13)
- What's Hot in Schizophrenia Research? (2016) (13)
- Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. (2019) (13)
- The Weaver GIRK2 Mutation Leads to Decreased Levels of Serum Thyroid Hormone: Characterization of the Effect on Midbrain Dopaminergic Neuron Survival (1999) (13)
- Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium (2022) (12)
- Adolescent testosterone influences BDNF and TrkB mRNA and neurotrophin–interneuron marker relationships in mammalian frontal cortex (2015) (12)
- An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure (2019) (12)
- Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder (2019) (11)
- Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats (2015) (11)
- Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trial (2018) (10)
- Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders (2018) (10)
- Trajectory of change in brain complement factors from neonatal to young adult humans (2020) (10)
- Peripheral complement is increased in schizophrenia and inversely related to cortical thickness (2021) (10)
- Reduction in IGF1 mRNA in the Human Subependymal Zone During Aging (2019) (10)
- Nuclear Receptors and Neuroinflammation in Schizophrenia (2018) (10)
- BDNF val66met genotype and schizotypal personality traits interact to influence probabilistic association learning (2014) (9)
- Expression analysis of the genes identified in GWAS of the postmortem brain tissues from patients with schizophrenia (2014) (9)
- Striatal but not frontal cortical up-regulation of the epidermal growth factor receptor in rats exposed to immune activation in utero and cannabinoid treatment in adolescence (2016) (9)
- Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain (2014) (9)
- Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls (2020) (8)
- Virtual Ontogeny of Cortical Growth Preceding Mental Illness (2022) (8)
- Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder (2021) (8)
- Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia (2022) (8)
- Kv channel interacting protein 3 expression and regulation by haloperidol in midbrain dopaminergic neurons (2009) (8)
- Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia (2019) (7)
- Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia (2021) (7)
- Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals (2022) (7)
- Identification of Sialyltransferase 8 B as a Generalized Susceptibility Gene for Psychotic and Mood Disorders on Chromosome 15 q 25-26 (2012) (7)
- Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder (2019) (7)
- Behavioural effects of high fat diet in adult Nrg1 type III transgenic mice (2020) (7)
- Effect of Immune Activation during Early Gestation or Late Gestation on Inhibitory Markers in Adult Male Rats (2020) (6)
- The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice (2018) (6)
- Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia (2020) (6)
- The impact of smoking status on cognition and brain morphology in schizophrenia spectrum disorders (2021) (6)
- Early‐life decline in neurogenesis markers and age‐related changes of TrkB splice variant expression in the human subependymal zone (2017) (6)
- Anti-N-methyl-D-aspartate encephalitis – a case study of symptomatic progression (2015) (6)
- Frontal and Parietal Contributions to Probabilistic Association Learning (2011) (6)
- FKBP5 Messenger RNA Increases After Adolescence in Human Dorsolateral Prefrontal Cortex (2016) (6)
- Promoter Specific Alterations of BDNF mRNA in Schizophrenia (2011) (6)
- Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disorders (2022) (5)
- S33. REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION (2019) (5)
- Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol (2020) (5)
- Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia (2018) (5)
- Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ9-tetrahydrocannabinol (D9-THC) (2018) (5)
- Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium (2022) (5)
- Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging (2022) (5)
- Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia (2012) (5)
- Reduced Insulin-Like Growth Factor Family Member Expression Predicts Neurogenesis Marker Expression in the Subependymal Zone in Schizophrenia and Bipolar Disorder. (2020) (4)
- O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS (2018) (4)
- Effects of handling on the behavioural phenotype of the neuregulin 1 type III transgenic mouse model for schizophrenia (2021) (4)
- Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process? (2019) (4)
- Restriction Enzyme Based Enriched L1Hs Sequencing (REBELseq): A Scalable Technique for Detection of Ta Subfamily L1Hs in the Human Genome (2020) (4)
- Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain (2022) (4)
- Expression of KCNH2-3.1 mRNA is increased in small neurons in the dorsolateral prefrontal cortex in patients with schizophrenia (2015) (3)
- Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes (2022) (3)
- Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: Evidence of a potential astrocyte pathology. (2021) (3)
- Considerations for optimal use of postmortem human brains for molecular psychiatry: lessons from schizophrenia. (2018) (3)
- Hormone modulation improves cognition in schizophrenia (2016) (3)
- Expression levels and cellular localization of ErbB receptors mRNAs in the dorsolateral prefrontal cortex in schizophrenia. (2005) (3)
- 66. Increased C3 and C4 Proteins in Serum of FEP and UHR Patients: Implications for Inflammatory Subtyping in SCZ (2017) (2)
- Maternal immune activation with high molecular weight poly(I:C) in Wistar rats leads to elevated immune cell chemoattractants (2022) (2)
- 107. Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation (2019) (2)
- N-Methyl- d -Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia (2021) (2)
- Reproductive hormones and schizophrenia (2015) (2)
- Erratum to “Expression of VGluT1 and VGAT mRNAs in human dorsolateral prefrontal cortex during development and in schizophrenia” [Brain Res. 1388 (2011) 22–31] (2011) (2)
- Developmental changes in human dopamine neurotransmission: cortical receptors and terminators (2012) (2)
- Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases (2022) (2)
- Where There’s Smoke, There’s Fire—But Who Is Lighting the Match? Bolstering Transcriptional Evidence for the Role of Nuclear Factor-κB in Neuroimmune Activation in Schizophrenia (2019) (2)
- Early Life Stress Alters Expression of Glucocorticoid Stress Response Genes and Trophic Factor Transcripts in the Rodent Basal Ganglia (2022) (2)
- A new suspect in the unsolved case of neuroinflammation in schizophrenia (2021) (1)
- The effect of adolescent testosterone on hippocampal BDNF and TrkB mRNA expression: relationship with cell proliferation (2015) (1)
- Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex (2012) (1)
- Cancer activates microglia to the same extent as chronic stress throughout stress neurocircuitry in a mouse model of breast cancer (2022) (1)
- Impact of gonadectomy on maturational changes in brain volume in adolescent macaques (2020) (1)
- Neuronal gene expression is decreased in prefrontal cortex in schizophrenia (2003) (1)
- Alterations in the Kynurenine Pathway in Depression With and Without Psychosis (2020) (1)
- 128. Dysregulation of Kynurenine Metabolism is Related to Proinflammatory Cytokines, Prefrontal Cortex Volume, and Attention in Schizophrenia (2017) (1)
- O1.5. ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA (2018) (1)
- Perturbed iron biology in the prefrontal cortex of people with schizophrenia (2023) (1)
- 770. C-Reactive Protein as a Marker of Inflammation in Acute Psychosis and Schizophrenia (2017) (1)
- 4.1 COGNITIVE RESERVE ATTENUATES AGE-RELATED COGNITIVE DECLINE IN THE CONTEXT OF ACCELERATED BRAIN AGEING IN SCHIZOPHRENIA-SPECTRUM DISORDERS: EVIDENCE FOR ACTIVE COMPENSATION (2019) (1)
- Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation (2022) (1)
- Alterations of neuregulin1 and ErbB4 expression in the cerebellum in schizophrenia (2005) (1)
- EFFECTS OF TRANSCRANIAL DIRECT CURRENT STIMULATION ON PROBABILISTIC FEEDBACK LEARNING IN PEOPLE WITH SCHIZOPHRENIA (2010) (1)
- 40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA (2018) (0)
- The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia (2022) (0)
- Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines (2020) (0)
- INTERACTION BETWEEN ESTROGEN RECEPTOR ALPHA AND TRKB SUGGEST CONVERGENCE IN DEVELOPMENTAL PATHWAYS IMPLICATED IN SCHIZOPHRENIA (2010) (0)
- Poster #120 PARALLEL INCREASES IN [H]MUSCIMOL AND [H]FLUMAZENIL BINDING IN THE DORSOLATERAL PREFRONTAL CORTEX IN SCHIZOPHRENIA ARE LINKED TO GABAA RECEPTOR A4 AND G2S MRNA SUBUNIT LEVELS RESPECTIVELY (2012) (0)
- Poster #129 DYNAMIC CHANGES IN MICRORNA EXPRESSION IN THE DEVELOPING HUMAN PREFRONTAL CORTEX (2012) (0)
- Title : Temporal proteomic profiling of postnatal human cortical development Running title : Integrative omics of postnatal cortical development (2018) (0)
- Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia (2022) (0)
- 15. ON THE ROAD TO CURING SCHIZOPHRENIA (2018) (0)
- Adolescent testosterone and postnatal hippocampal neurogenesis in male rats (2015) (0)
- F174. Testosterone Modulation of Sex Steroid and Dopamine–Related mRNAs During Adolescence in the Mesolimbic Pathway (2019) (0)
- DIFFERENTIAL EXPRESSION OF SYNAPTIC AND INTERNEURON GENES IN THE AGING HUMAN PREFRONTAL CORTEX (2018) (0)
- F157. Transcriptional Changes in the Stress Pathway are Related to Symptoms in Schizophrenia and to Mood in Schizoaffective Disorder (2019) (0)
- Abstract 2045: Analysis of the matrisome in malignant gliomas reveals architectural heterogeneity of the tumor microenvironment and discloses a prognostic signature of extracellular matrix targets (2023) (0)
- High blood cytokine levels are linked to decreased verbal fluency and Broca's area volume in schizophrenia (2013) (0)
- S21: Schizophrenia: Oxidative Stress and Inflammation in Schizophrenia: Functional consequences (2016) (0)
- Effect of Immune Activation during Early Gestation or Late Gestation on Inhibitory Markers in Adult Male Rats (2020) (0)
- Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia (2021) (0)
- 23.4 MAPPING MAJOR MOLECULAR CHANGES IN THE DEVELOPMENT OF THE HUMAN CORTEX (2018) (0)
- SU103 UBIQUITINATED PROTEINS ARE ELEVATED IN THE BLOOD AND BRAIN OF INDIVIDUALS WITH SCHIZOPHRENIA (2019) (0)
- Statement on Reciprocity between the Royal College of Psychiatrists and the Royal Australian and New Zealand College of Psychiatrists (1996) (0)
- PROTRACTED DEVELOPMENT OF CORTICAL INHIBITION AND ITS RELATIONSHIP TO SCHIZOPHRENIA (2010) (0)
- High Blood Cytokine Levels Are Linked to Decreased Verbal Fluency and Broca'S Area Volume Reduction in Schizophrenia (2015) (0)
- Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia (2019) (0)
- Peripheral Inflammation Markers Identify a Subset of Patients With Schizophrenia and Related Psychoses who Display Intellectual Decline From Premorbid Levels (2020) (0)
- Lower brain pH as a shared endophenotype of psychotic disorders (2016) (0)
- Dysregulated affect in schizophrenia and bipolar disorder; PFC-amygdala decoupling during emotional regulation (2011) (0)
- Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging (2022) (0)
- schizophrenia. This new interpretation also raises many additional questions, in particular: if the cortex is attempting to self-repair in schizophrenia, then why does this process presumably fail? (2014) (0)
- Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia (2023) (0)
- The NRG1/ErbB4 signaling pathway in schizophrenia. From upstream effectors to downstream intracellular signaling networks (2007) (0)
- Genomic stability and DNA repair in lymphoblasts from patients sie schizophrenia (2010) (0)
- Intellectually Categorized Subgroups in Schizophrenia: Independent Replication and Hippocampal Volumetric Reduction in the Deteriorated Group (2015) (0)
- Correction: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals (2022) (0)
- THE PARADOX OF TESTOSTERONE SIGNALING IN MALES WITH SCHIZOPHRENIA (2012) (0)
- Speaker 1: Vibeke Catts, Australia (2016) (0)
- GRIN2B gene expression is increased in the anterior cingulate cortex in major depression. (2023) (0)
- Connectivity shapes cortical thickness reductions in schizophrenia: ‘Regions that together’ (2019) (0)
- Correction: Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals. (2023) (0)
- DEVELOPMENTAL REGULATION OF GABAA RECEPTOR a-SUBUNITS IN THE HUMAN BRAIN (2008) (0)
- O11.2. ELEVATION OF MACROPHAGE-RELATED TRANSCRIPTS IN THE MIDBRAIN IN SCHIZOPHRENIA (2020) (0)
- Speaker 2: Celso Arango (2016) (0)
- O11.5. INCREASED INFLAMMATION AND MACROPHAGE INFILTRATION IS ASSOCIATED WITH ALTERED SUBEPENDYMAL ZONE NEUROGENESIS IN SCHIZOPHRENIA BUT NOT BIPOLAR DISORDER (2020) (0)
- Acknowledgement to Referees (2016) (0)
- Second generation antipsychotics reduce treatment discontinuation rates compared with haloperidol (2008) (0)
- 73. Efficacy of Transcranial Direct Current Stimulation in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial (2017) (0)
- Neuroimmune transcriptome changes in brains of psychiatric and neurological disorder patients (2022) (0)
- Poster #131 NEUROPATHOLOGY OF VITAMIN D RECEPTOR AND RETINOID X RECEPTORS IN SCHIZOPHRENIA (2012) (0)
- Astrocytic Regulation of Basal Ganglia Dopamine/D2-Dependent Behaviors (2021) (0)
- MARKERS OF SYNAPTIC PLASTICITY ARE REDUCED IN THE DORSOLATERAL PREFRONTAL CORTEX OF PATIENTS WITH SCHIZOPHRENIA (2010) (0)
- SA107 ELEVATED PERIPHERAL EXPRESSION OF NEUREGULIN-1 (NRG1) MRNA ISOFORMS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA (2019) (0)
- Dr. Law and Colleagues Reply (2005) (0)
- M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS (2020) (0)
- Poster #113 ESTROGEN RECEPTOR ALPHA GENOTYPE AND COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA (2012) (0)
- M174. REDUCED CHEMOKINE SIGNALLING CAPACITY IS ASSOCIATED WITH INHIBITORY INTERNEURON DYSFUNCTION IN SUBCORTICAL BRAIN REGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER (2020) (0)
- Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder (2017) (0)
- Adolescent cannabinoid exposure after maternal immune activation increases proliferation in the adult subventricular zone (2015) (0)
- 767. Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia (2017) (0)
- Insights into the molecular changes associated with postnatal human brain development: an integrated transcriptomics and proteomics study (2017) (0)
- Expression of Neuregulin-1, a schizophrenia susceptibility gene, in the normal human brain and in schizophrenia (2004) (0)
- P525. Cell Type-Specific Manifestations of Cortical Thickness Heterogeneity in Schizophrenia (2022) (0)
- Schizophrenia and Cognitive Dysfunction Associated with the Estrogen Receptor 1 Genotype (2016) (0)
- Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra (2012) (0)
- Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations (2023) (0)
- (2018). Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (0)
- Changes in cytokine and cytokine receptor levels during postnatal development of the human dorsolateral prefrontal cortex (2023) (0)
- Developmental influences on schizophrenia-like cognitive and neurophysiological outcomes in a rat model of maternal immune challenge (2015) (0)
- EVIDENCE OF NEUROGENESIS IN THE SUBEPENDYMAL ZONE OF POSTNATAL HUMAN BRAIN (1999) (0)
- EXPRESSION OF DOUBLECORTIN DURING HUMAN CORTICAL DEVELOPMENT (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Cynthia Shannon Weickert?
Cynthia Shannon Weickert is affiliated with the following schools:
